Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 01/28: (KOSS) (HIMS) (EYPT) Higher; (AMC) (BBY) (NOK) (EXPR) Lower (more...)

January 28, 2021 9:29 AM

Pre-pen Stock Movers

Koss Corporation (NASDAQ: KOSS) 78% HIGHER; adds to recent short-squeeze gains.

AMC Entertainment Holdings, Inc. (NYSE: AMC) 35.4% LOWER; profit-taking after rising 301% intra-day Wednesday on short-squeeze. Trading firms restrict trading.

Him & Hers Health (NYSE: HIMS) 29% HIGHER; Cathie Wood's ARK Investment Management disclosed it bought 461,611 shares.

BlackBerry Limited (NYSE: BB) 25% LOWER; Trading firms restrict trading.

Nokia Corporation (NYSE: NOK) 22% LOWER; Trading firms restrict trading.

Express, Inc. (NYSE: EXPR) 22% LOWER; Trading firms restrict trading.

Bed Bath & Beyond Inc. (NASDAQ: BBBY) 19% LOWER; Trading firms restrict trading.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) 9% HIGHER; Cantor Fitzgerald initiates with an Overweight rating and price target of $22.00.

Accelerate Diagnostics (NASDAQ: AXDX) 9% LOWER; filed a $150 million mixed securities shelf.

Whirlpool (NYSE: WHR) 4.4% LOWER; reported Q4 EPS of $6.64, $0.57 better than the analyst estimate of $6.07. Revenue for the quarter came in at $5.94 billion versus the consensus estimate of $5.59 billion. Whirlpool sees FY2021 EPS of $19.00-$20.00, versus the consensus of $19.10.

Tesla (NASDAQ: TSLA) 4.4% LOWER; reported Q4 EPS of $0.80, $0.15 worse than the analyst estimate of $0.95. Revenue for the quarter came in at $10.74 billion versus the consensus estimate of $10.2 billion.

Applied Genetic Technologies Corporation (Nasdaq: AGTC) 4.3% HIGHER; providing an update on its ongoing clinical trials in patients with achromatopsia (ACHM). The Company believes the additional data reported today provides the first reported quantitative evidence of improvements in visual sensitivity, supports the positive patient reported outcomes and provides a path forward to collect additional data to fully realize the potential of this treatment.

ServiceNow (NYSE: NOW) 1.5% HIGHER; reported Q4 EPS of $1.17, $0.12 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.23 billion versus the consensus estimate of $1.21 billion.

Categories

Special Reports

Next Articles